It seems we have a national passion for prostate biopsies. A million men are biopsied every year. Two hundred thousand of them will be diagnosed with prostate cancer and about half of these with Low-Risk disease, a condition that can be safely monitored without immediate treatment. READ THE FULL ARTICLE HERE > https://www.verywell.com/zytiga-the-next-step-after-lupron-2782332